• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

窦周隙血管病:一种新实体的提出与描述。

Porto-sinusoidal vascular disease: proposal and description of a novel entity.

机构信息

University Clinic for Visceral Surgery and Medicine, Inselspital, Bern, Switzerland; Department of Biomedical Research, University of Bern, Bern, Switzerland.

Service d'Hépatologie, Hôpital Beaujon, Clichy, France; Centre de Recherche de l'Inflammation, Inserm and Université Paris Diderot, Paris, France.

出版信息

Lancet Gastroenterol Hepatol. 2019 May;4(5):399-411. doi: 10.1016/S2468-1253(19)30047-0.

DOI:10.1016/S2468-1253(19)30047-0
PMID:30957754
Abstract

Portal hypertension in the absence of portal vein thrombosis and without cirrhosis, but with mild or moderate alterations of liver histology (eg, obliterative venopathy, nodular regenerative hyperplasia, or incomplete septal cirrhosis) is being increasingly recognised. Owing to the heterogeneity of causes and histological findings, a substantial number of terms have been used to describe such idiopathic non-cirrhotic portal hypertension. Patients with the same clinical and histological features exist, but without portal hypertension at the time of diagnosis. Therefore, improved criteria are needed to define this form of liver disease. Here, we propose the term porto-sinusoidal vascular disease, since all lesions found involve the portal venules or sinusoids. The definition of this entity is based on the characteristic absence of cirrhosis with or without signs of portal hypertension or histological lesions. The presence of known causes of liver disease does not rule out porto-sinusoidal vascular disease, but specific causes of vascular liver disease are excluded from its definition. The diagnosis of porto-sinusoidal vascular disease is based on liver biopsy and might include signs specific for portal hypertension with normal or mildly elevated liver stiffness values and no complete portal vein thrombosis. We provide simple diagnostic criteria, because agreement on a uniform nomenclature is an essential requirement for future collaborative studies.

摘要

在不存在门静脉血栓且无肝硬化的情况下,伴有轻微或中度肝组织学改变(如闭塞性静脉病、结节性再生性增生或不完全间隔性肝硬化)的门静脉高压症正日益受到关注。由于病因和组织学发现的异质性,已经使用了大量术语来描述这种特发性非肝硬化性门静脉高压症。存在具有相同临床和组织学特征的患者,但在诊断时没有门静脉高压。因此,需要改进标准来定义这种形式的肝病。在这里,我们提出了门腔静脉血管病的术语,因为所有发现的病变都涉及门静脉小静脉或窦。该实体的定义基于特征性的无肝硬化,伴有或不伴有门静脉高压或组织学病变的存在。已知肝病的病因并不排除门腔静脉血管病,但将特定的血管性肝病病因排除在其定义之外。门腔静脉血管病的诊断基于肝活检,可能包括具有正常或轻度升高的肝硬度值且无完全门静脉血栓形成的门静脉高压的特征性表现。我们提供了简单的诊断标准,因为统一命名法的共识是未来合作研究的基本要求。

相似文献

1
Porto-sinusoidal vascular disease: proposal and description of a novel entity.窦周隙血管病:一种新实体的提出与描述。
Lancet Gastroenterol Hepatol. 2019 May;4(5):399-411. doi: 10.1016/S2468-1253(19)30047-0.
2
Porto-sinusoidal vascular disorder.窦周隙血管障碍。
J Hepatol. 2022 Oct;77(4):1124-1135. doi: 10.1016/j.jhep.2022.05.033. Epub 2022 Jun 9.
3
Porto-sinusoidal Vascular Disease and Portal Hypertension.窦前性门静脉血管病和门静脉高压症。
Clin Liver Dis. 2024 Aug;28(3):455-466. doi: 10.1016/j.cld.2024.03.004. Epub 2024 May 1.
4
Pathology of idiopathic non-cirrhotic portal hypertension.特发性非肝硬化性门静脉高压症的病理学。
Virchows Arch. 2018 Jul;473(1):23-31. doi: 10.1007/s00428-018-2355-8. Epub 2018 Apr 12.
5
Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease.非肝硬化门静脉高压症——门静脉窦状血管疾病的诊断挑战
World J Gastroenterol. 2020 Jun 14;26(22):3000-3011. doi: 10.3748/wjg.v26.i22.3000.
6
Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension.识别发生非肝硬化性门静脉高压症高风险的患者。
Hepat Med. 2021 Nov 3;13:105-111. doi: 10.2147/HMER.S282674. eCollection 2021.
7
Porto-sinusoidal Vascular Disease: Classification and Clinical Relevance.门静脉-肝窦状隙血管疾病:分类及临床相关性
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101396. doi: 10.1016/j.jceh.2024.101396. Epub 2024 Mar 12.
8
Porto-sinusoidal vascular disorder (PSVD): Application of new diagnostic criteria in a multicenter cohort of patients.窦周隙血管障碍(PSVD):新诊断标准在多中心患者队列中的应用。
Dig Liver Dis. 2024 Feb;56(2):291-296. doi: 10.1016/j.dld.2023.07.023. Epub 2023 Aug 5.
9
Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.特发性非肝硬化门静脉高压症与肝内门-体静脉分流性疾病:当前数据综述
Gastroenterology Res. 2021 Apr;14(2):49-65. doi: 10.14740/gr1376. Epub 2021 Apr 21.
10
Obliterative portal venopathy without portal hypertension: an underestimated condition.无门静脉高压的闭塞性门静脉病:一种被低估的病症。
Liver Int. 2016 Mar;36(3):454-60. doi: 10.1111/liv.12936. Epub 2015 Sep 6.

引用本文的文献

1
Listen to Patient's Gut: A Case Report of a Woman With Fatigue and Bruising.倾听患者的直觉:一例疲劳与瘀斑女性患者的病例报告
Gastro Hep Adv. 2025 Jun 5;4(9):100714. doi: 10.1016/j.gastha.2025.100714. eCollection 2025.
2
Role of Gut-Derived Endotoxins in Porto-Sinusoidal Vascular Disorder: Comparison Between patients with and without portal hypertension.肠道源性内毒素在门静脉-肝窦血管病变中的作用:门静脉高压患者与非门静脉高压患者的比较
Liver Int. 2025 Sep;45(9):e70277. doi: 10.1111/liv.70277.
3
EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implications.
欧洲肝脏研究学会研究生课程报告:慢性肝病中的血管生物学及其临床管理意义
JHEP Rep. 2025 Mar 19;7(8):101399. doi: 10.1016/j.jhepr.2025.101399. eCollection 2025 Aug.
4
Trastuzumab Emtansine (T-DM1)-Induced Porto-Sinusoidal Vascular Disorder: A Case Report.曲妥珠单抗-美坦新偶联物(T-DM1)诱导的门-肝窦状血管病变:一例报告
Cureus. 2025 Jun 19;17(6):e86333. doi: 10.7759/cureus.86333. eCollection 2025 Jun.
5
Splanchnic hemodynamic parameters measured with 4D flow MRI can diagnose severe portal hypertension.用四维血流磁共振成像测量的内脏血流动力学参数可诊断重度门静脉高压。
Eur Radiol. 2025 Jul 15. doi: 10.1007/s00330-025-11799-4.
6
Role of Vascular Liver Diseases in Hepatocellular Carcinoma Development.血管性肝病在肝细胞癌发生中的作用。
Cancers (Basel). 2025 Jun 20;17(13):2060. doi: 10.3390/cancers17132060.
7
Porto-Sinusoidal Vascular Disorder: An Under-Recognized Liver Manifestation in Turner Syndrome.门静脉-肝窦血管紊乱:特纳综合征中一种未被充分认识的肝脏表现。
J Clin Med. 2025 Jun 5;14(11):3979. doi: 10.3390/jcm14113979.
8
Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms.BCR::ABL1阴性骨髓增殖性肿瘤患者门静脉高压的非侵入性分层
Liver Int. 2025 Jun;45(6):e70098. doi: 10.1111/liv.70098.
9
Prognostic Role of Endoscopic Ultrasound Guided Direct Portal Pressure Gradient Measurement in Porto-Sinusoidal Vascular Disorder.内镜超声引导下直接门静脉压力梯度测量在门静脉-肝窦血管疾病中的预后作用
Liver Int. 2025 May;45(5):e70096. doi: 10.1111/liv.70096.
10
Nodular Regenerative Hyperplasia Is a Frequent Finding in Explanted Livers of Patients With Maple Syrup Urine Disease.结节性再生性增生在枫糖尿症患者的移植肝脏中很常见。
Pediatr Dev Pathol. 2025 Jul-Aug;28(4):273-280. doi: 10.1177/10935266251333007. Epub 2025 Apr 17.